Login to Your Account



ImaRx Shares Spike on Sale of Urokinase to Microbix

By Tiffany Turner


Thursday, May 8, 2008
In a deal that sent shares of ImaRx Therapeutics Inc. soaring and spurred the creation of a spin-off company, Microbix Biosystems agreed to acquire urokinase inventory and related assets from ImaRx for $17 million in cash. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription